A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases

PHASE3CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Acute Bronchitis
Interventions
DRUG

Azithromycin SR

Trial Locations (19)

312-0057

Pfizer Investigational Site, Hitachi-Naka

309-1793

Pfizer Investigational Site, Kasama

302-0118

Pfizer Investigational Site, Moriya

302-0005

Pfizer Investigational Site, Toride

300-0053

Pfizer Investigational Site, Tsuchiura

232-0021

Pfizer Investigational Site, Yokohama

239-0821

Pfizer Investigational Site, Yokosuka

981-4321

Pfizer Investigational Site, Kami-gun

852-8511

Pfizer Investigational Site, Shigesato-cho, Nagasaki

950-2087

Pfizer Investigational Site, Shindoori, Niigata-shi

576-0016

Pfizer Investigational Site, Katano

190-0163

Pfizer Investigational Site, Akiruno

182-0006

Pfizer Investigational Site, Chōfu

182-0022

Pfizer Investigational Site, Chōfu

187-0042

Pfizer Investigational Site, Kodaira

164-0012

Pfizer Investigational Site, Nakano City

158-0095

Pfizer Investigational Site, Setagaya City

140-0011

Pfizer Investigational Site, Shinagawa

992-0045

Pfizer Investigational Site, Yonezawa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY